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pléïotropique (ou multidrogue). Le but de cette expérience était de déterminer si une nouvelle classe 
d’antibiotique pouvait être identifiée en analysant l’expression de gène du Pseudomonas aeruginosa en
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There is an urgent need for novel classes of antibiotics as 
most species of bacteria have at least one antibiotic resis-
tant gene, resulting in the bacteria being almost impossible 
to eradicate. In the past 40 years, only two new classes of 
antibiotics have been developed.  It is essential that novel an-
tibiotics be developed to combat the increasing threat from 
multi-drug resistance bacteria. The purpose of this experiment 
was to determine if potential novel classes of antibiotics could 
be identified by analyzing Pseudomonas aeruginosa gene ex-
pression in response to 13 antimicrobial substances, these be-
ing 9 chemical compounds, 3 plant tinctures, and silver nitrate. 
The antimicrobial substances and 14 antibiotics were tested 
against 96 mutated strains of Pseudomonas aeruginosa. Each 
strain has been mutated to produce light when one specific 
gene is expressed. This allowed me to determine which genes 
were affected by each substance. Cluster analyses were run 
on the results to determine statistically similar patterns of gene 
expression.  The nine antimicrobial chemicals were sorted into 
two statistically distinct groups from the antibiotics tested. This 
indicates that they form two potential novel classes of antibiot-
ics, with modes of action distinct from the tested antibiotics.  
The plant tinctures had methods of action similar to that of Ka-
namycin, an aminoglycoside, indicating their potential as nov-
el antibiotics. This is a novel experiment as the antimicrobial 
substances have not previously been analyzed for their ge-
nomic effects and the mutant Pseudomonas aeruginosa has 
not previously been used as an indicator of gene expression. 
Il y a un besoin alarmant pour de nouvelles classes d’antibioti-
ques puisque la plupart des espèces de bactéries détiennent 
au moins un gène de résistance aux antibiotiques, ce qui rend 
les bactéries presque impossibles à éradiquer. Au cours des 
quarante dernières années, seulement deux nouvelles class-
es d’antibiotiques ont été développées. Il est essentiel que de 
nouveaux antibiotiques soient développés afin de lutter contre 
la menace croissante de bactéries détenant une résistance
   
Nowadays, the emergence of 
bacterial resistance to antibiotics 
is a common phenomenon, often 
as a result of evolutionary process 
occurs during antibacterial drug 
therapy. The number of bacte-
rial strains that no longer respond 
to treatment with the most com-
mon antibiotics has increased at 
an alarming rate during the past 
few decades. Albeit the fact that 
many alternative strategies have 
been introduced to treat bacterial 
diseases these days, there is still 
a strong demand for discover-
ing new classes of antibacterial 
agents.
In this paper, Sarah Hyslop ex-
amined the potential antibacte-
rial effect of 13 antimicrobial sub-
stances by testing the responding 
gene expression of Pseudomo-
nas aeruginosa.  The results were 
also compared with the gene ex-
pression levels under the treat-
ments of 14 antibiotics to infer the 
mechanism of action. Her pro-
tocol of screening large number 
of antimicrobial substances may 
provide an inspiring perspective 
for pharmaceutical institutions in 
future antibiotic development.
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présence de 13 substances antimicrobiennes, soient 9 composés chimiques, 3 teintures de plantes et du 
nitrate d’argent. Les substances antimicrobiennes et 14 antibiotiques ont été testés contre 96 souches 
mutées de Pseudomonas aeruginosa. Chaque souche a été mutée afin de produire de la lumière quand 
un gène en particulier est exprimé. Ceci m'a permis de déterminer quels gènes sont affectés par chaque 
substance. Des partitionnements de données ont été effectués sur les résultats pour déterminer des 
modèles statistiquement similaires d’expression de gènes. Les neuf produits chimiques antimicrobiens 
ont été classés en deux groupes statistiquement distincts parmi les antibiotiques testés. Cela démontre 
qu'ils forment deux nouvelles classes d'antibiotiques, avec des modes d’action distincts par rapport aux 
antibiotiques testés. Les teintures végétales avaient des méthodes d'action similaire à celle de la Kana-
mycine, un aminoglycoside, démontrant leur potentiel en tant que nouveaux antibiotiques. Ceci est une 
nouvelle expérience ingénieuse puisque les substances antimicrobiennes n’avaient pas été analysées 
auparavant pour leurs effets génomiques et les mutants du Pseudomonas aeruginosa n’avaient pas été 
auparavant utilisés en tant qu’indicateurs d’expression de gène.
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Background
In the past, most bacterial infections could be 
treated through the use of antibiotics. Today, there 
are antibiotic resistance genes in almost every spe-
cies of bacteria, resulting in the bacteria being almost 
impossible to eradicate.  In the United States, ap-
proximately 2 million people acquire hospital related 
infections each year, resulting in 90,000 deaths; 70% 
of these infections are caused by bacteria that are 
resistant to at least one antibiotic.[1] Antibiotic resis-
tance is a significant health risk, but the development 
of new antibiotics is declining. Pharmaceutical com-
panies often focus on developing drugs with a higher 
financial benefit than short term use antibiotics. In 
the past 40 years, only two new classes of antibiot-
ics have been developed.[2] It is essential that novel 
classes of antibiotics be developed to combat multi-
drug resistant species of bacteria. 
P. aeruginosa is a gram negative, rod shaped bac-
terial species that exhibits high levels of resistance 
to many antibiotics, making it an excellent model for 
studying and classifying novel antibiotics. It is an op-
portunistic pathogen, capable of surviving in both 
aerobic and anaerobic conditions and commonly im-
plicated in nosocomial infections. Several character-
istics of P. aeruginosa contribute to its antibiotic re-
sistance: multidrug efflux pumps, antibiotic resistant 
genes,  low membrane permeability, and the ability to 
form biofilms.
Purpose
The purpose of the experiment was to determine 
whether 13 antimicrobial substances have the po-
tential to become novel antibiotics by comparing 
the gene expressions induced by the antimicrobials 
to those induced by known antibiotics.  The 13 anti-
microbial substances and 14 antibiotics were tested 
against 96 mutated strains of Pseudomonas aerugi-
nosa.  Each P. aeruginosa strain was mutated to pro-
duce light when one specific gene was expressed. 
This allowed for identification of which genes were 
affected by each antimicrobial substance and antibi-
otic, and patterns of gene expression were analyzed. 
Differences in gene expression indicated a method 
of action different than that of the tested antibiotics, 
suggesting a new class of antibiotics.
Hypothesis
I hypothesized that the antimicrobial substances 
tested would affect P. aeruginosa gene expression in 
a manner different than that of the established anti-
biotics, indicating a potential novel class of antibiot-
ics. By analyzing the gene expression patterns, the 
mechanisms of action of the antimicrobial substanc-
es could be determined, and the potential of these 
substances as novel classes of antibiotics could be 
evaluated. 
Procedure
Engineering 96 mutant P. aeruginosa strains
To produce each mutant strain, a lux operon was 
randomly inserted into the P. aeruginosa genome us-
ing plasmids and transposons. The lux operon is nat-
urally found in A. fischeri and regulates the luciferin-
luciferase system, which produces light; therefore, the 
mutant P. aeruginosa will emit light when the gene in 
which the lux operon has been inserted is expressed. 
Gene sequencing was used to identify the locus of 
the lux operon insertion. The protocol was repeated to 
generate 96 mutant strains of P. aeruginosa.
Antibiotics Antimicrobial  
Chemicals
Plant Tinctures
Amp: Ampicillin PxnB: Polymyxin B Ci: Ciprofloxacin 3C6 9E3 Uu: Uva ursi
Cef: Ceftazidime Col: Colistin Tp: Trimethoprim 4E7 9G3 Bb: Barberry
Cb: Carbenicillin Km: Kanamycin Cm: Chloramphenicol 5C10 9H8 Gs: Goldenseal
Pip: Piperacillin   Gm: Gentamicin Chx: Chlorhexidine 6D5 10F8 Other Antimicrobials
Az: Aztreonam Tm: Tobramycin 9D7 AgNO3: Silver Nitrate
Figure 1. Cluster Analysis illustrating statistically significant similarities between P. aeruginosa gene expres-
sion in response to 14 antibiotics, 9 antimicrobial chemicals, 3 plant tinctures, and silver nitrate.  Substances 
with statistically similar modes of action are grouped together.  Green represents gene over expression.  Red 
represents gene under expression.  Type of cluster analysis used was a complete linkage, hierarchal cluster.
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Establishing Sub-Lethal Concentrations of the 
Antibiotics and Experimental Chemicals
The double dilution method was used to create 
growth curves of P. aeruginosa in response to each 
substance. The growth curves were analyzed to find 
the minimum inhibitory concentration (MIC) of each 
substance. The sub-lethal concentration used was 
one-quarter of the MIC value. Those concentrations 
were then tested again to ensure they did not eradi-
cate the bacteria. 
Determining Gene Expression Patterns Induced 
by the Substances
To determine which P. aeruginosa genes each an-
tibiotic and antimicrobial substance affected, I tested 
fourteen antibiotics, nine antimicrobial chemicals, 
three plant tinctures, and silver nitrate against the 96 
mutant strains of P. aeruginosa. The chemical formu-
las of the antimicrobials cannot be disclosed for patent 
purposes, but they are identified as 3C6, 4E7, 5C10, 
6D5, 9D7, 9E3, 9G3, 9H8, and 10F8. The plant tinc-
tures were Uva ursi, Barberry and Goldenseal. The 
antibiotics were Kanamycin, Gentamicin, Tobramy-
cin, Piperacillin, Ceftazidime, Aztreonam, Ampicillin,
Carbenicillin, Polymyxin B, Colistin, Ciprofloxacin, 
Trimethoprim, Chlorhexidine, and Chloramphenicol. 
96 mutant strains of P. aeruginosa were inocu-
lated into a 96-well plate and incubated at 37oC. Af-
ter 18 hours, a 96 peg stamper was used to transfer 
these strains to twenty-seven 384-well plates, each 
containing one antibiotic or experimental antimicro-
bial substance. Each mutant strain was stamped 
four times in each 384-well plate, ensuring that there 
would be four replicates of each bacteria-substance 
interaction. An empty 384 well plate containing only 
media served as the control. The plates were incu-
bated at 37oC for 21 hours. A Perkin Elmer Wallac 
Victor 1420 Multilabel Counter was used to quantify 
the photons of light emitted from each well, due to the 
expression of the lux operon, in counts per second 
(CPS). Heat maps were generated to illustrate the 
gene expression patters induced by the substances, 
and complete linkage and average linkage hierarchal 
cluster analyses were run to determine statistically 
similar patterns of gene expression. Similar results 





New Antimicrobials – Group 1
Aminoglycosides
New Antimicrobials – Group 2
Outliers
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Antimicrobials Generate Two Distinct Patterns of 
Bacterial Gene Expression
The cluster analysis grouped the 9 antimicrobial 
chemicals into two groups that are statistically dis-
tinct from the antibiotics tested, indicating that they 
form two potential novel classes of antibiotics (Figure 
1). The P. aeruginosa genes responded differently to 
the antimicrobial chemicals than to the antibiotics, 
suggesting separate mechanisms of action. Genes 
clearly illustrating these differences are acsA (well 
G06), cysI (well D10),  PA3157 (well F07),  plsX (well 
E03),  PA4153 (well E12), and trpE (well F10).  In both 
antimicrobial groups, genes acsA, and PA4153 were 
strongly overexpressed while genes cysI, PA3157 
and plsX were underexpressed in comparison to the 
antibiotics. The two groups are distinct in their effect 
on gene trpE (well F10), which was strongly overex-
pressed in response to group 1 antimicrobials and 
strongly underexpressed in response to group 2. The 
antibiotics had little effect on trpE.
Plant Tinctures Generate Similar Gene Expres-
sion Profiles as Kanamycin
The cluster analysis grouped Uva ursi, Barberry, 
and Goldenseal with Kanamycin, an aminoglycoside 
that inhibits protein synthesis. It is important to note 
that the plant tinctures also caused gene overexpres-
sion across the board, perhaps because they each 
contain multiple active compounds.
Silver Nitrate Generates Similar Expression Pro-
file as Chlorhexidine
The cluster analysis indicated that silver nitrate and 
chlorhexidine induced similar changes in gene ex-
pression that did not resemble those of the the other 
antibiotics or antimicrobials.
Discussion
Cluster analysis identified two novel groups of anti-
biotics within the 9 antimicrobials tested. Furthermore, 
the pattern of genes affected by each group indicate 
their potential mechanisms of action. Genes acsA, 
cysI, plsX, PA4153, and trpE regulate cellular metabo-
lism, specifically the breakdown of carbon compounds 
through cellular respiration for the production of ATP. 
Genes PA3157 and plsX regulate molecular compo-
nents of the bacterial cell membrane, such as phos-
pholipids. It is possible that the two groups of antimi-
crobials deregulate both cell membrane maintenance 
and energy production. Further testing of the antimi-
crobial chemicals is required to verify their potential as
novel classes of antibiotics. The experiments should 
be replicated using both sub lethal and lethal con-
centrations of the antimicrobials, and other bacterial 
species (i.e. gram positive) should be tested as well.
The cluster analysis grouped Uva ursi, Barberry, 
and Goldenseal with Kanamycin, an aminoglycoside 
that inhibits protein synthesis through direct inter-
action with the 30S ribosomal subunit. Although no 
evidence suggests that the plant tinctures interact 
with the ribosome, it is interesting to note that they 
may have similar effects on bacterial gene expres-
sion as Kanamycin does. Silver nitrate was grouped 
with Chlorhexidine, which eradicates bacterial cells 
through cell membrane disruption. This agrees with 
previous reports that silver is capable of disrupting 
the cell membrane and supports the use of silver ni-
trate as an antiseptic and disinfectant.[3]
Conclusion
I have identified two groups of antimicrobial chemi-
cals which have the potential to become novel 
classes of antibiotics, as they exhibit modes of ac-
tion different from those of known antibiotics. More 
importantly, I have developed a drug screening pro-
tocol that effectively infers the mechanisms of action 
of various antimicrobial substances. This study en-
hances our knowledge of antimicrobials and can lead 
to the discovery of novel antibiotics, which addresses 
our urgent need for new antibiotics as bacteria con-
tinue to develop resistance to our current ones.
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Review of The Road to Novel Antibiotics
The study authored by Hyslop was designed to explore the modes of action for a set of antimicrobial sub-
stances. In general, this report is well written, and outlines the experimental hypothesis, procedure, results and 
conclusions in a clear concise manner.   The experiments were well designed and resulted in novel and informa-
tive results well presented by the researcher.
The abstract is well written, and concisely captures the purpose of the experiment, essential background in-
formation, and the main results and conclusions of the study.
The background very briefly states the need for the development of novel classes of antibiotics due to the 
rise of antibiotic resistance among bacteria. The section makes proper use of a relevant reference paper.  This 
section for this report would benefit from a more extensive literature search into the subject area of antibiotic 
resistance mechanisms and current classes of antibiotics. This would give the reader a better sense of how the 
results of this study contribute to the knowledge of novel antimicrobial agents and their form of action.
Another item that would have been appropriate here is the source of the 13 antimicrobial substances tested 
in this study. It would be good to have a reference to any previously published papers on these substances. 
Throughout the report one question this reviewer had in mind was whether these unknown substances had 
proven antimicrobial activities. Since they are labeled antimicrobials, I assumed they do, but a reference to that 
here, or at least a mention, would have been useful.
The purpose section has a well written summary articulating the reason for the study, which is to test a set of 
antimicrobial compounds for novel modes of action, as such compounds would represent potential new drugs 
that can be used on bacteria resistant to the modes of action of currently used antibiotics. As this section explains 
the bacterial mutant strains used in the study, it would have been good to make a mention of what genes were 
represented among the 96 mutant strains: were they randomly selected genes? Were they genes representing 
different pathways? Where did the collection of mutants come from?
The hypothesis section was well written and concise. The procedure was very well written, including sufficient 
detail about the protocols, materials and equipment used to be able to duplicate the experiment. The procedure 
shows evidence of multiple replicates used in the experiment, which ensures robust results. All the materials 
used are well defined.
The research results in this paper were excellent, well written and laid with proper use of a colorful figure that 
is properly labeled and explained. In the discussion sections, there is an excellent explanation of the study's re-
sults, along with referencing to previously published results that agreed with one of this study's results.
The conclusions are very well written. Perhaps it would have benefited from tying in identification of novel 
pathways of action such as this study does with identification of novel antimicrobial compounds. How does one 
identify these to begin with? This would make the connection for the reader more clear of how an unknown sub-
stance goes from discovery, to pathway identification, to use as a novel antibiotic. One other useful addition to 
this section would have been ideas on how to follow up on this very important study.
Overall, this is a very good paper, well written, easy to follow with language and figures, highlighting the im-
portance of the results, as well as presenting novel information that will be helpful to the field. The author did well 
in including an acknowledgment section, a list of references, and a bibliography.  Ms. Hyslop’s excellent research 
paper outlines one way that novel pathways of action for antimicrobials can be identified and thus circumvent 
known mechanisms of antimicrobial resistance in bacteria. The study identifies two classes of compounds that 
represent novel modes of action. Excellent work!
Marcelo Vinces, Ph.D., Director, Center for Learning, Education and Research in the Sciences, Oberlin Col-
lege, Oberlin, Ohio
